Cyklodash is a game idea that could encourage more people to explore cities by bike. The game is designed to make more people want to start cycling to work. That’s the hope of the team behind the concept that recently won the Flemingsberg Science Award.
This year, Flemingsberg Science is contributing to the national business plan competition Venture Cup with its own prize: the Flemingsberg Science Award, which celebrates ideas from Flemingsberg that contribute to a better world.
A smart addition to the patient record system at Karolinska University Hospital has been developed into a product thanks to a Kraftcentrum Flemingsberg project. The result is Clicknote, the brainchild of doctor Joakim Crafoord.
If you study, work or live in Flemingsberg, you can now submit your business idea in a preliminary round of Sweden’s national business competition, the Venture Cup – an initiative that Flemingsberg Science hopes will encourage the development of ideas that contribute to a better world.
When the founders of Joyship were looking for a place to develop their meeting app, they found exactly what they were looking for at Flemingsberg Science. Office space at the heart of Campus Flemingsberg not only offered a quiet workplace – it also provided access to an extensive contact network.
A new flooring technology can drastically reduce fall injuries among the elderly. Rubber spikes activate in the event of a sudden impact and can prevent, for example, femoral fractures. The technology is based on KTH research and was initially developed with the support of the Kraftcentrum Flemingsberg program.
ANA Futura is officially inaugurated at Campus Flemingsberg – a unique research environment focused on bringing down boundaries: boundaries between research and education, as well as between academia and the community.
Sprint Bioscience and LG Chem have signed a cooperation and licensing agreement for research, development and commercialization of drug candidates. “We’re delighted about the agreement with LG Chem, an ideal partner to further develop this programme,” says Dr Anders Åberg, Sprint Bioscience CEO.